Robert Francomano's Net Worth
$145 Thousand
Who is Robert Francomano?
Robert Francomano does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SELLAS Life Sciences Group, Inc., and STEMLINE THERAPEUTICS INC.
SEC CIK
Robert Francomano's CIK is 0001797467
Past Insider Trading and Trends
2023 was Robert Francomano's most active year for acquiring shares with 2 total transactions. Robert Francomano's most active month to acquire stocks was the month of January. 2020 was Robert Francomano's most active year for disposing of shares, totalling 5 transactions. Robert Francomano's most active month to dispose stocks was the month of November. 2020 saw Robert Francomano paying a total of $0.00 for 105,939 shares, this is the most they've acquired in one year. In 2020 Robert Francomano cashed out on 257,493 shares for a total of $43,490.80, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SELLAS Life Sciences Group, Inc. (SLS) Snapshot price: $1.16
Chief Commercial OfficerRobert Francomano owns 40,918 units of Common Stock which is worth $47,464.88 and 20,918 units of Class A Common Stock which is worth $24,264.88. From 2022 to 2024 Robert Francomano acquired a total of 32,000 shares in SELLAS Life Sciences Group, Inc., Robert also disposed a total of 1,082 shares of SELLAS Life Sciences Group, Inc. equalling to $1,168.56.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +95.61% | 20K |
—
|
—
| 40.92K |
Jan 22
| |||
Form 4
| -4.92% | -1.08K |
$1.08 | -$1,168.56 | 20.92K |
Dec 6
| |||
Form 4
|
∞
| 12K |
—
|
—
| 12K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
STEMLINE THERAPEUTICS INC No price found
Chief Commercial OfficerRobert Francomano used to own units in Common Stock but no longer holds any shares there. In the year 2019 Robert Francomano acquired a total of 105,939 shares in STEMLINE THERAPEUTICS INC, Robert also disposed a total of 210,163 shares of STEMLINE THERAPEUTICS INC equalling to $72,430.29.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -200.89K |
—
|
—
|
0
|
Jun 10
| |||
Form 4
| -0.14% | -272.00 |
$11.51 | -$3,130.72 | 197.66K |
May 4
| |||
Form 4
| -0.64% | -1.27K |
$5.00 | -$6,330.00 | 197.93K |
Mar 9
| |||
Form 4
| +102.60% | 100.88K |
$6.72 | -$34,030.08 | 199.2K |
Feb 7 - Feb 10
| |||
Form 4
| -2.64% | -2.67K |
$10.84 | -$28,939.49 | 98.32K |
Dec 23 - Dec 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||